South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
基本信息
- 批准号:10820346
- 负责人:
- 金额:$ 72.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-09 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdministrative SupplementAffectAreaAwardBackBiomedical ResearchBiotechnologyBusinessesCaringClinical ResearchCollaborationsCountryCountyDevelopmentDisciplineDisclosureDissemination and ImplementationDiverse WorkforceEconomicsEducationEducational CurriculumEnvironmentFosteringFoundationsFundingGeographic LocationsGrantGrowthHealthHealth PrioritiesHealth systemHealthcareHealthcare SystemsHeterogeneityHomeHumanIndividualInformaticsIntellectual PropertyInterdisciplinary StudyInterventionInvestmentsLearningLicensingLinkMarketingMedicalMedically Underserved AreaMethodologyMethodsMissionOccupationsParentsPennsylvaniaPopulation HeterogeneityPositioning AttributeProcessProductivityPublic HealthRecording of previous eventsResearchResearch InstituteResearch PersonnelResearch TrainingResourcesRuralScienceSecureSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSourceSouth CarolinaStructureSupport SystemSystemTechnologyTherapeuticTrainingTraining and InfrastructureTranslatingTranslational ResearchTranslationsUniversitiesVisionWorkcommercializationdigital healthexperienceflexibilityhealth disparityimprovedinnovationinnovative technologiesinventionknowledge basemedically underservedmeetingsmethod developmentnew technologyoutreachparent grantpatient populationpractice settingproduct developmentprogramsresearch and developmentrural underservedsabbaticalsocial health determinantssuccesstechnological innovationtelehealthtooltranslational barriertranslational therapeuticsunderserved community
项目摘要
PROJECT SUMMARY – SCTR INSTITUTE Parent Award UL1-TR001450
Since 2009, the South Carolina Clinical and Translational Research Institute (SCTR) has transformed the
research environment across South Carolina (SC) by creating a Learning Health System that supports high-
quality clinical and translational research (CTR) and fosters collaboration and innovation. Headquartered at
the Medical University of South Carolina (MUSC), SCTR has engaged stakeholders and created statewide
partnerships to improve care and address social determinants of health across SC. However, greater than
75% of SC is rural, and all 46 counties contain areas designated as medically underserved, so health
disparities remain an issue. Over the next five years, SCTR will strengthen its outreach to these medically
underserved areas through collaboration with the Clemson University Health Extension Program and the
MUSC Telehealth Center of Excellence. With a focus on implementation and dissemination as well as
discovery, we will develop and demonstrate innovative technologies and outreach to improve the health of
our stakeholders. We will build on prior successes and introduce innovative approaches to expand CTR
across SC through the following aims:
Aim 1. Extend and enhance high-quality, innovative, flexible curricula and training experiences for all levels
of the CTR workforce, with particular emphasis on enhancing workforce heterogeneity and team science.
Aim 2. Engage a diverse group of stakeholders as active partners in CTR to address health care priorities
while enhancing the scientific knowledge base about collaboration and engagement.
Aim 3. Promote greater inclusion acrossthe full translational spectrumof research by engaging investigators
from many disciplines and patient populations from diverse demographic backgrounds and geographic
areas.
Aim 4. Develop, demonstrate and disseminate innovative methods and processes to address barriers and
accelerate the translation of research discoveries to improvements in human health that can be generalized
to a variety of practice settings.
Aim 5. Enhance the conduct of translational research through the development of secure and innovative
informatics and digital health solutions, tools and methodologies that affect every aspect of CTR.
SCTR’s vision is to be a major force in facilitating the translation of innovative science into practice to
address the health priorities of the citizens of SC and beyond. To achieve this vision, SCTR’s mission is to
catalyze the development of methods and technologies that lead to more efficient translation of biomedical
discoveries into interventions that improve individual and public health. SCTR will serve as the statewide
academic home for CTR, one that is well-integrated with SC’s healthcare systems and provides essential
support for innovative, efficient, multidisciplinary research and research training. We will work within SCTR,
with our partners across SC and with the CTSA Consortium to realize this vision.
项目摘要 - SCTR研究所父母奖UL1-TR001450
自2009年以来,南卡罗来纳州的临床和转化研究所(SCTR)已经改变了
通过建立一个支持高级的学习卫生系统,南卡罗来纳州(SC)的研究环境
优质的临床和转化研究(CTR)以及培养合作与创新。总部位于
南卡罗来纳州医科大学(MUSC),SCTR与利益相关者订婚并在全州创建了
合作伙伴关系,以改善护理和解决社会决定者的健康状况。但是,大于
SC的75%是粗糙的,所有46个县都包含指定为医学欠缺的地区,因此健康
差异仍然是一个问题。在接下来的五年中,SCTR将在医学上加强其对这些的宣传
通过与克莱姆森大学健康扩展计划合作和
MUSC远程医疗卓越中心。专注于实施和传播以及
发现,我们将开发和展示创新技术和推广,以改善
我们的利益相关者。我们将基于先前的成功,并引入创新的方法来扩展CTR
通过以下目的整个SC:
目标1。扩展并增强各级高质量,创新,灵活的课程和培训经验
CTR劳动力的尤其是增强劳动力异质性和团队科学。
AIM 2。与CTR中的一群利益相关者一起作为积极合作伙伴,以解决医疗保健重点
同时增强了有关协作和参与的科学知识基础。
目标3。通过吸引研究人员,促进在完整的翻译谱系中更大的包含
来自潜水员人群和地理的许多学科和患者人群
区域。
目标4。开发,演示和传播创新方法和流程,以解决障碍和
加快研究发现的翻译,以改善人类健康,可以推广
到各种练习环境。
目标5。通过开发安全和创新的发展,增强翻译研究的行为
信息和数字健康解决方案,影响CTR各个方面的工具和方法。
SCTR的愿景是成为促进创新科学转化为实践的主要力量
解决SC及其他地区公民的健康优先事项。为了实现这一愿景,SCTR的使命是
催化方法和技术的开发,从而导致更有效地翻译生物医学
发现改善个人和公共卫生的干预措施。 SCTR将作为全州
CTR的学术住所,与SC的医疗保健系统融合在一起,并提供了必不可少的
支持创新,高效,多学科研究和研究培训。我们将在SCTR中工作
与我们的合作伙伴一起,与CTSA财团一起实现这一愿景。
项目成果
期刊论文数量(617)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HuR as a molecular target for cancer therapeutics and immune-related disorders.
- DOI:10.1016/j.addr.2022.114442
- 发表时间:2022-09
- 期刊:
- 影响因子:16.1
- 作者:
- 通讯作者:
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion.
- DOI:10.1186/s12879-022-07250-4
- 发表时间:2022-03-12
- 期刊:
- 影响因子:3.7
- 作者:Mingora CM;Garcia BA;Mange KC;Yuen DW;Ciesielska M;van Ingen J;Flume PA;Dorman SE
- 通讯作者:Dorman SE
Sex/Gender Differences in Screening for Autism Spectrum Disorder: Implications for Evidence-Based Assessment.
- DOI:10.1080/15374416.2018.1437734
- 发表时间:2019-11
- 期刊:
- 影响因子:0
- 作者:Evans SC;Boan AD;Bradley C;Carpenter LA
- 通讯作者:Carpenter LA
Effects of growing-up milk supplemented with prebiotics and LCPUFAs on infections in young children.
- DOI:10.1097/mpg.0000000000000252
- 发表时间:2014-04
- 期刊:
- 影响因子:2.9
- 作者:Chatchatee P;Lee WS;Carrilho E;Kosuwon P;Simakachorn N;Yavuz Y;Schouten B;Graaff PL;Szajewska H
- 通讯作者:Szajewska H
Prevalence and predictors of phthalate exposure in pregnant women in Charleston, SC.
- DOI:10.1016/j.chemosphere.2017.11.019
- 发表时间:2018-03
- 期刊:
- 影响因子:8.8
- 作者:Wenzel AG;Brock JW;Cruze L;Newman RB;Unal ER;Wolf BJ;Somerville SE;Kucklick JR
- 通讯作者:Kucklick JR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATHLEEN T. BRADY其他文献
KATHLEEN T. BRADY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATHLEEN T. BRADY', 18)}}的其他基金
Patients decline buprenorphine from the emergency department CTN:0107 add on
患者拒绝从急诊科使用丁丙诺啡 CTN:0107 添加
- 批准号:
10666250 - 财政年份:2022
- 资助金额:
$ 72.49万 - 项目类别:
South Carolina Clinical and Translational Research Institute (SCTR)
南卡罗来纳州临床和转化研究所 (SCTR)
- 批准号:
10200510 - 财政年份:2020
- 资助金额:
$ 72.49万 - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
10158966 - 财政年份:2020
- 资助金额:
$ 72.49万 - 项目类别:
Coordinated medical treatment of opioid use disorder and infectious disease
阿片类药物使用障碍和传染病的协调医疗
- 批准号:
10210317 - 财政年份:2019
- 资助金额:
$ 72.49万 - 项目类别:
Coordinated medical treatment of opioid use disorder and infectious disease
阿片类药物使用障碍和传染病的协调医疗
- 批准号:
10457318 - 财政年份:2019
- 资助金额:
$ 72.49万 - 项目类别:
Coordinated medical treatment of opioid use disorder and infectious disease
阿片类药物使用障碍和传染病的协调医疗
- 批准号:
9980520 - 财政年份:2019
- 资助金额:
$ 72.49万 - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
9930823 - 财政年份:2019
- 资助金额:
$ 72.49万 - 项目类别:
Southern Consortium Node of the Clinical Trials Network
临床试验网络南方联盟节点
- 批准号:
9765878 - 财政年份:2018
- 资助金额:
$ 72.49万 - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
9560529 - 财政年份:2015
- 资助金额:
$ 72.49万 - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
9085864 - 财政年份:2015
- 资助金额:
$ 72.49万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686546 - 财政年份:2023
- 资助金额:
$ 72.49万 - 项目类别:
Equipment and Instrument Infrastructure Improvement for the MMRRC at UC Davis
加州大学戴维斯分校 MMRRC 的设备和仪器基础设施改进
- 批准号:
10805721 - 财政年份:2023
- 资助金额:
$ 72.49万 - 项目类别:
Circadian Clock and Myc-dependent Regulation of Cellular Transformation
生物钟和细胞转化的 Myc 依赖性调节
- 批准号:
10767049 - 财政年份:2023
- 资助金额:
$ 72.49万 - 项目类别:
MMPC-Live Consortium Marketing and Outreach
MMPC-Live 联盟营销和推广
- 批准号:
10901723 - 财政年份:2023
- 资助金额:
$ 72.49万 - 项目类别:
Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment
改善癌症治疗期间和治疗后症状管理研究中心协调中心
- 批准号:
10833736 - 财政年份:2023
- 资助金额:
$ 72.49万 - 项目类别: